Regulon

Regulon: R-2831

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
140.53354610Pr-117Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
10512 ENSG00000075223 SEMA3C Q99985
23555 ENSG00000099282 TSPAN15 O95858
54941 ENSG00000101695 RNF125 Q96EQ8
7103 ENSG00000127324 TSPAN8 P19075
2317 ENSG00000136068 FLNB A0A804HJC2
5168 ENSG00000136960 ENPP2 Q13822
10435 ENSG00000149798 CDC42EP2 O14613
5305 ENSG00000150867 PIP4K2A P48426
2114 ENSG00000157557 ETS2 P15036
5580 ENSG00000163932 PRKCD Q05655
4815 ENSG00000171840 NINJ2 Q9NZG7
4642 ENSG00000176658 MYO1D O94832
6840 ENSG00000197321 SVIL O95425
26585 ENSG00000282046 GREM1 H0YLY2

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
MIDOSTAURINKITSmall moleculeINHIBITORVascular endothelial growth factor receptor 2 inhibitor40
SOTRASTAURINPRKD3Small moleculeINHIBITORProtein kinase C (PKC) inhibitor20
UCN-01CDK4Small moleculeINHIBITOR3-phosphoinositide dependent protein kinase-1 inhibitor20
DELCASERTIBPRKCDProteinINHIBITORProtein kinase C delta inhibitor20
ZIRITAXESTATENPP2Small moleculeINHIBITORAutotaxin inhibitor30
GSK-690693PRKACBSmall moleculeINHIBITORProtein kinase C (PKC) inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2831

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs